Analytical methods | ||
---|---|---|
Comparative study | #1 | |
Chromatography | LC | |
Ion source | ESI | |
Positive/Negative mode | both | |
Mass analyzer | TripleTOF | |
Identification level | MS/MS |
Sample information | ||
---|---|---|
Comparative study | #1 | |
Country | China | |
Specimen | pleural effusion | |
Marker function | diagnosis | |
Participants(Case) | Cancer type | NSCLC, SCLC, anaplastic carcinoma |
Stage | – | |
Number | 32 | |
Gender (M,F) | 13, 19 | |
Mean age (range) (M,F) | 72.8 ± 11.4 | |
Smoking status | smoker, non-smoker | |
Participants(Control) | Type | pulmonary tuberculosis |
Number | 18 | |
Gender (M,F) | 10, 8 | |
Mean age (range) (M,F) | 59.7 ± 25.2 | |
Smoking status | smoker, non-smoker |
Data processing and metabolite identification | |
---|---|
Data processing software | PeakView, LipidView (AB SCIEX), XCMS |
Database search | HMDB |
Statistical analysis | |
---|---|
Differential analysis method | t-test, OPLS-DA |
Classification method | ROC curve analysis |
Survival analysis method | – |
Metabolite | Author-emphasized biomarkers | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
---|---|---|---|---|---|---|---|
ceramide | – | – | – | – | 1.72e-05 | – | – |
oleic acid | – | – | – | – | 8.23e-08 | – | – |
Metabolite | Author-emphasized biomarkers | Cutoff value | AUROC (95%CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|
ceramide | – | – | 0.726–0.938 | 72.2 | 90.6 | – |
oleic acid | – | – | 0.866–0.996 | 84.4 | 100 | – |